Cargando…
Interstitial lung disease is a risk factor for ischaemic heart disease and myocardial infarction
OBJECTIVES: Despite many shared risk factors and pathophysiological pathways, the risk of ischaemic heart disease (IHD) and myocardial infarction (MI) in interstitial lung disease (ILD) remains poorly understood. This lack of data could be preventing patients who may benefit from screening for these...
Autores principales: | Clarson, Lorna Elise, Bajpai, Ram, Whittle, Rebecca, Belcher, John, Abdul Sultan, Alyshah, Kwok, Chun Shing, Welsh, Victoria, Mamas, Mamas, Mallen, Christian D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282497/ https://www.ncbi.nlm.nih.gov/pubmed/32114515 http://dx.doi.org/10.1136/heartjnl-2019-315511 |
Ejemplares similares
-
Tea consumption and risk of ischaemic heart disease
por: Li, Xia, et al.
Publicado: (2017) -
Incident cardiovascular events and imaging phenotypes in UK Biobank participants with past cancer
por: Raisi-Estabragh, Zahra, et al.
Publicado: (2023) -
Right atrium and cryptogenic ischaemic stroke in the young: a case–control study
por: Pöyhönen, Pauli, et al.
Publicado: (2021) -
Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatment
por: Gynnild, Mari Nordbø, et al.
Publicado: (2022) -
Systematic review of clinical guidelines for lipid lowering in the secondary prevention of cardiovascular disease events
por: Brown, Rosemary Elisabeth, et al.
Publicado: (2020)